Multiple IPOs are scheduled to price in the coming weeks of November 2026, including Rezera Inc. on November 12, vVARDIS Holding AG and Windward Bio Group AG on November 13, and Anthropic on November 19 with terms set for an estimated $61 billion raise at a roughly $968 billion midpoint valuation. Recent S-1 filings and amendments for these and other issuers, such as American Barrick Gold Corp, confirm active roadshows and underwriter commitments from major banks. With 2026 already tracking as the second-strongest year on record by proceeds raised, equity market conditions and regulatory timelines support additional listings before year-end. Key near-term catalysts include final pricing decisions and any last-minute delays tied to market volatility or SEC review.